The interferon response inhibits HIV particle production by induction of TRIM22.

Treatment of human cells with Type 1 interferons restricts HIV replication. Here we report that the tripartite motif protein TRIM22 is a key mediator. We used transcriptional profiling to identify cellular genes that were induced by interferon treatment and identified TRIM22 as one of the most stron...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephen D Barr, James R Smiley, Frederic D Bushman
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
Acceso en línea:https://doaj.org/article/f3b3335734414ad680f757a4f2b52cf0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3b3335734414ad680f757a4f2b52cf0
record_format dspace
spelling oai:doaj.org-article:f3b3335734414ad680f757a4f2b52cf02021-11-25T05:46:42ZThe interferon response inhibits HIV particle production by induction of TRIM22.1553-73661553-737410.1371/journal.ppat.1000007https://doaj.org/article/f3b3335734414ad680f757a4f2b52cf02008-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18389079/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Treatment of human cells with Type 1 interferons restricts HIV replication. Here we report that the tripartite motif protein TRIM22 is a key mediator. We used transcriptional profiling to identify cellular genes that were induced by interferon treatment and identified TRIM22 as one of the most strongly up-regulated genes. We confirmed, as in previous studies, that TRIM22 over-expression inhibited HIV replication. To assess the role of TRIM22 expressed under natural inducing conditions, we compared the effects of interferon in cells depleted for TRIM22 using RNAi and found that HIV particle release was significantly increased in the knockdown, implying that TRIM22 acts as a natural antiviral effector. Further studies showed that TRIM22 inhibited budding of virus-like particles containing Gag only, indicating that Gag was the target of TRIM22. TRIM22 did not block the release of MLV or EIAV Gag particles. Inhibition was associated with diffuse cytoplasmic staining of HIV Gag rather than accumulation at the plasma membrane, suggesting TRIM22 disrupts proper trafficking. Mutational analyses of TRIM22 showed that the catalytic amino acids Cys15 and Cys18 of the RING domain are required for TRIM22 antiviral activity. These data disclose a pathway by which Type 1 interferons obstruct HIV replication.Stephen D BarrJames R SmileyFrederic D BushmanPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 4, Iss 2, p e1000007 (2008)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Stephen D Barr
James R Smiley
Frederic D Bushman
The interferon response inhibits HIV particle production by induction of TRIM22.
description Treatment of human cells with Type 1 interferons restricts HIV replication. Here we report that the tripartite motif protein TRIM22 is a key mediator. We used transcriptional profiling to identify cellular genes that were induced by interferon treatment and identified TRIM22 as one of the most strongly up-regulated genes. We confirmed, as in previous studies, that TRIM22 over-expression inhibited HIV replication. To assess the role of TRIM22 expressed under natural inducing conditions, we compared the effects of interferon in cells depleted for TRIM22 using RNAi and found that HIV particle release was significantly increased in the knockdown, implying that TRIM22 acts as a natural antiviral effector. Further studies showed that TRIM22 inhibited budding of virus-like particles containing Gag only, indicating that Gag was the target of TRIM22. TRIM22 did not block the release of MLV or EIAV Gag particles. Inhibition was associated with diffuse cytoplasmic staining of HIV Gag rather than accumulation at the plasma membrane, suggesting TRIM22 disrupts proper trafficking. Mutational analyses of TRIM22 showed that the catalytic amino acids Cys15 and Cys18 of the RING domain are required for TRIM22 antiviral activity. These data disclose a pathway by which Type 1 interferons obstruct HIV replication.
format article
author Stephen D Barr
James R Smiley
Frederic D Bushman
author_facet Stephen D Barr
James R Smiley
Frederic D Bushman
author_sort Stephen D Barr
title The interferon response inhibits HIV particle production by induction of TRIM22.
title_short The interferon response inhibits HIV particle production by induction of TRIM22.
title_full The interferon response inhibits HIV particle production by induction of TRIM22.
title_fullStr The interferon response inhibits HIV particle production by induction of TRIM22.
title_full_unstemmed The interferon response inhibits HIV particle production by induction of TRIM22.
title_sort interferon response inhibits hiv particle production by induction of trim22.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/f3b3335734414ad680f757a4f2b52cf0
work_keys_str_mv AT stephendbarr theinterferonresponseinhibitshivparticleproductionbyinductionoftrim22
AT jamesrsmiley theinterferonresponseinhibitshivparticleproductionbyinductionoftrim22
AT fredericdbushman theinterferonresponseinhibitshivparticleproductionbyinductionoftrim22
AT stephendbarr interferonresponseinhibitshivparticleproductionbyinductionoftrim22
AT jamesrsmiley interferonresponseinhibitshivparticleproductionbyinductionoftrim22
AT fredericdbushman interferonresponseinhibitshivparticleproductionbyinductionoftrim22
_version_ 1718414494719279104